This document provides an introduction and overview of Marpel Pharma Group and its subsidiaries Latin Health Group and Latin Health International. Some key points: - Marpel Pharma Group is a leading pharmaceutical and medical device distributor in Latin America, headquartered in Costa Rica with offices throughout Latin America. - Its subsidiaries Latin Health Group and Latin Health International distribute medical devices and pharmaceuticals across Mexico, Central America, and South America. - The presentation outlines Latin Health International's strategy to become the leading distributor of Israeli medical technologies across Latin America by establishing distribution networks and managing regulatory and marketing activities. - Several Israeli-developed medical device products are highlighted as potential additions to Latin Health International's

1. Title Page
Introduction Presentation
May, 2015
Welcome to
Latin America
Introduction presentation
Medica, 2015
Omer Inbar, Managing Director
o.inbar@lhi-med.com

2. Marpel Pharma Group
• Marpel Pharma Group, established in 2000 and
headquartered in San Jose, Costa Rica, is a leading
distributor of Pharmaceuticals and Medical Devices in
Latin America.
• With additional offices in Mexico, Guatemala, El
Salvador, Honduras & Argentina, Marpel utilizes its
global infrastructure to provide its customers cutting
edge products and outstanding service.
• Marpel Pharma operates two subsidiary companies:
Latin Health Group & Latin Health International
covering Mexico, Central America & the Andean
region.

3. Marpel Pharma Group
Marpel Pharma specializes in the distribution of pharmaceuticals. The company
specializes in working with government dominated markets, registering and selling over
200 products in fields including: CNS, Respiratory, Gastrointestinal, Antibiotics.
Marpel Pharma has established operations in India & China geared to ensure local
markets with the highest quality generic pharmaceuticals.

4. Latin Health Group – Devices Sales
Latin Health Group is the Medical Devices
subsidiary, operating in Central America &
Mexico in the following divisions:
• General surgery & laparoscopy
• Infection control
• Orthopedics, trauma & rehab
• Interventional radiology
We exclusively represent over 30 brands
including:

5. Meet some of our team members…
Costa Rica HQ
Guatemala Honduras El Salvador Argentina

7. 33 countries, 600 million person
population, geographically covering
14% of the planet’s surface.
Brazil & Mexico, the two largest
markets in population and GDP,
representing around 50% of LATAM’s
GDP.
Introduction to Latin America
Source: UN, IMF

8. Top ten Latin American countries
GDP at $6 trillion is the fourth
largest economy in the world.
Low GDP/Capita vs. OECD but
significantly higher than India &
China.
Strong increases in HealthCare
expenditures, tech acceptance.
2012
OECD 72.2
LATAM 41
China 42.3
India 12.6
Russia 63.8
Internet Users, per 100 people
Introduction to Latin America
Source: UN, IMF

9. Strong Urbanization Trends
People per Square
Kilometre
Highly Urban Countries More than 200 people
Medium-High Urban Countries 100 – 200 people
Medium Urban Countries 50 – 100 people
Low-Medium Urban Countries 10 – 50 people
Low Urban Countries Less than 10 people
Mexico City
Population 2025:
24.6 million
GDP 2025:
$713.5 billion
Bogota
Population
2025:
11.4 million
GDP 2025:
$298.0 billion
Rio de Janeiro
Population 2025:
13.6 million
GDP 2025:
$327.1 billion
Buenos Aires
Population 2025:
15.5 million
GDP 2025:
$327.1 billion
Sao Paulo
Population 2025:
23.2 million
GDP 2025:
$643.9 billion
Santiago
Population 2025:
7.1 million
Belo Horizonte
Population 2025:
6.6 million
Guadalajara
Population 2025:
5.7 million
Source: United Nations, Department of Economic and Social Affairs Statistics, Frost & Sullivan and other regional and country level statistics bureau
Lima
Population
2025:
11.5 million
Mega Cities
in 2025
Emerging Mega Cities
Mega Cities:
By 2025, it is
expected that
86% of the
population will
be living in
urban areas.

10. Latin America Medical Devices Market
Total Imports Imports as %
of Market
Brazil $2.8B 72%
Mexico $2.5B 95%
Argentina $0.4B 89%
Colombia $0.5B 86%
Venezuela $0.9B 95%
Chile $0.4B 96%
CAGR 2013-2017 is
estimated at 7.7%, 3rd
fastest in the world.

11. Latin Health International
The Vision: To be the gateway for
Medical Devices & Pharmaceuticals for
all of Latin America.

12. Latin Health International
Outside of Brazil
& Mexico, Latin
America
markets are low
priority for the
small-medium
sized
manufacturer.
High diversification
makes it
challenging for
manufacturers to
address each
territory
individually.
The Background The Opportunity

13. Our philosophy is to create a REAL win-win situation when we are dealing with
manufacturers:
- Establish & manage a distribution network for the manufacturer.
- Manage product education and marketing activities alongside the distributor.
- Utilize market experience and know-how, bridge cultural differences.
- Create a business model that is 100% success driven.
Latin Health International

14.  Each product will go through a
process that begins with initial
screening and ends with our
account management of the
product.
 Initially in Israel, looking to
expand to EU & US.
Latin Health International
Screening,
local
market
evaluation
Cross
country
evaluation
Territory
Selection
Agreements
& Reg.
Initial Sales
Account
Mgmt.

15. Model Benefits
LHI
• Dramatically reduced
inventory and
operational expenses.
• Highly profitable
• Geographical location
• Exposure to new
markets
• Utilize market know-
how
Manufacturers
• Success model
• Low management
time requirements.
• Diversification of
global footprint.
• Regulatory support.
• Maintain solid
visibility.

16. First Target: Israel HealthCare Technologies

17. Targeting Israeli Market – Why?

18. Breakdown of Sub-Segments Med Devices

19. Targeting Israel Market
Global VC Investments
2010-2014
Israel VC Investments
in Life Sciences

20. Global HealthCare Companies in Israel

21. Product Portfolio
An inflatable balloon
retractor indicated to retract
organs for improved vision
during laparoscopic surgery.

22. IceSense 3 System IceCure Medical has developed a third generation
cryoablation system for breast tumors that easier,
faster and safer than competition.
Product Portfolio

23. DASH – Disposable, Absorbent, Secure Hold
is an absorbent, soft tissue retractor
comprised of a silicone coated steel mesh.
The device is being used in a wide range of
surgical procedures (gynecology, urology,
general, vascular) of the abdomen.
Benefits include: Superior exposure & access
of surgical field, ease of use, reduced risk of
retained foreign body post op.
Product Portfolio

24. Product Portfolio

25. Product Portfolio

26. First Total Lift Standing Bed in Market
- Important addition to early mobility trends
- Indications include ICU, burn units, pulmonary,
bariatrics.
Product Portfolio

27. An ultrasound-based GPS device created to accurately track fetal station and
position upon entering the mother’s pelvis. Removes the need for blind
interpretation of cervical dilation and fetal positioning by maternity care providers.
Product Portfolio

28. A line of Dynamic Tissue systems that utilize the skin & body’s anatomical
processes to dramatically improve wound closure outcomes:
- Next step in closure of difficult to close wounds
- Improve aesthical outcome of suture site.
Product Portfolio

29. Introduction Presentation
May, 2015
Thank You!!!